Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay 2

被引:237
作者
Opalka, D
Lachman, CE
MacMullen, SA
Jansen, KU
Smith, JF
Chirmule, N
Esser, MT
机构
[1] MRL Wayne, Virus & Cell Biol, Wayne, PA 19087 USA
[2] Merck Res Labs, Microbial Vaccines, West Point, PA 19486 USA
关键词
D O I
10.1128/CDLI.10.1.108-115.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several different methods have been developed to quantitate neutralizing antibody responses to human papillomaviruses (HPVs), including in vivo neutralization assays, in vitro pseudoneutralization assays, competitive radioimmunoassays (cRIAs), and enzyme-linked immunosorbent assays. However, each of these techniques possesses one or more limitations that preclude testing large numbers of patient sera for use in natural history studies and large vaccine clinical trials. We describe here a new multiplexed assay, by using the Luminex Laboratory MultiAnalyte Profiling (LabMAP3) assay system, that can simultaneously quantitate neutralizing antibodies to human papillomavirus types 6, 11, 16, and 18 in 50 mul of serum. The HPV-Luminex competitive immunoassay measures titers of polyclonal antibodies in serum capable of displacing phycoerythrin-labeled detection monoclonal antibodies binding to conformationally sensitive, neutralizing epitopes on the respective virus-like particles. This competitive Luminex immunoassay was found to be as sensitive, accurate, and precise as the currently used cRIAs. An effective HPV vaccine will most likely require several distinct genotypes to protect against multiple cancer causing papillomaviruses. The HPV-Luminex immunoassay should prove to be a useful tool in simultaneously quantitating antibody immune responses to multiple HPV genotypes for natural history infection studies and for monitoring the efficacy of prospective vaccines.
引用
收藏
页码:108 / 115
页数:8
相关论文
共 50 条
  • [11] HUMAN PAPILLOMAVIRUS TYPE-6 AND TYPE-11 HAVE ANTIGENICALLY DISTINCT STRONGLY IMMUNOGENIC CONFORMATIONALLY DEPENDENT NEUTRALIZING EPITOPES
    CHRISTENSEN, ND
    KIRNBAUER, R
    SCHILLER, JT
    GHIM, SJ
    SCHLEGEL, R
    JENSON, AB
    KREIDER, JW
    [J]. VIROLOGY, 1994, 205 (01) : 329 - 335
  • [12] Christiansen C, 1996, J MED VIRTUAL REALIT, V1, P6
  • [13] Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae
    Cook, JC
    Joyce, JG
    George, HA
    Schultz, LD
    Hurni, WM
    Jansen, KU
    Hepler, RW
    Ip, C
    Lowe, RS
    Keller, PM
    Lehman, ED
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 1999, 17 (03) : 477 - 484
  • [14] Fulton RJ, 1997, CLIN CHEM, V43, P1749
  • [15] SELF-ASSEMBLY OF HUMAN PAPILLOMAVIRUS TYPE-1 CAPSIDS BY EXPRESSION OF THE L1 PROTEIN ALONE OR BY COEXPRESSION OF THE L1 AND L2 CAPSID PROTEINS
    HAGENSEE, ME
    YAEGASHI, N
    GALLOWAY, DA
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (01) : 315 - 322
  • [16] VIRUSES IN HUMAN CANCERS
    HAUSEN, HZ
    [J]. SCIENCE, 1991, 254 (5035) : 1167 - 1173
  • [17] SEQUENCE DETERMINATION OF HUMAN PAPILLOMAVIRUS TYPE 6A AND ASSEMBLY OF VIRUS-LIKE PARTICLES IN SACCHAROMYCES-CEREVISIAE
    HOFMANN, KJ
    COOK, JC
    JOYCE, JG
    BROWN, DR
    SCHULTZ, LD
    GEORGE, HA
    ROSOLOWSKY, M
    FIFE, KH
    JANSEN, KU
    [J]. VIROLOGY, 1995, 209 (02) : 506 - 518
  • [18] Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae
    Hofmann, KJ
    Neeper, MP
    Markus, HZ
    Brown, DR
    Muller, M
    Jansen, KU
    [J]. JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 465 - 468
  • [19] STUDIES ON VACCINATION AGAINST PAPILLOMAVIRUSES - PROPHYLACTIC AND THERAPEUTIC VACCINATION WITH RECOMBINANT STRUCTURAL PROTEINS
    JARRETT, WFH
    SMITH, KT
    ONEIL, BW
    GAUKROGER, JM
    CHANDRACHUD, LM
    GRINDLAY, GJ
    MCGARVIE, GM
    CAMPO, MS
    [J]. VIROLOGY, 1991, 184 (01) : 33 - 42
  • [20] PAPILLOMAVIRUS L1 MAJOR CAPSID PROTEIN SELF-ASSEMBLES INTO VIRUS-LIKE PARTICLES THAT ARE HIGHLY IMMUNOGENIC
    KIRNBAUER, R
    BOOY, F
    CHENG, N
    LOWY, DR
    SCHILLER, JT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) : 12180 - 12184